Biden administration requests $22.5B in supplemental COVID-19 aid

The White House requested from Congress $22.5 billion in supplemental COVID-19 relief funds and urged quick action.

Advertisement

These funds would be used for oral antiviral treatments, monoclonal antibodies and pre-exposure prophylaxis, testing initiatives and vaccine efforts, according to a March 2 letter by Office of Management and Budget Acting Director Shalanda Young.

The letter requests Congress to address these needs in a government funding bill by the March 11 funding deadline.

The White House also requested $10 billion in additional support for Ukraine.

“I urge the Congress to act expeditiously in considering this important request,” the letter states. “I and my staff stand ready to work with you to address these urgent funding needs, as well as on other emergency funding needs, such as additional resources to continue recovery efforts from past natural disasters.”

Read more here.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.